Endocrinology Advisor Conclusion The 2025 GLP-1 guidelines reflect a paradigm shift in the management of type 2 diabetes, emphasizing the multifaceted benefits of these agents
Treatment must be initiated within specialist weight management services (Tier 3) as part of a comprehensive programme that includes dietary modification, increased physical activity, and behavioural support
Carnitine, Glucose Utilization and Insulin Resistance Ive talked a lot in previous articles about how blood sugar imbalances are extremely common in Hashimotos
Tiaminal B12 injection is also an option, with its own benefits
The HPRA is also concerned that products containing Melanotan 2 are increasingly being targeted towards young people by using bright colours, flavours, and branding
Otherwise, feel free to contact us (we may even add your question to the list)